系列名称 |
产品名称(中文) |
纯度 |
英文名称 |
CAS |
分子式 |
分子量 |
外观 |
保存条件 |
保存期 |
入库量 |
可提供资料 |
结构图 |
头孢唑林系列 |
头孢唑林杂质A |
95.81% |
Cefazolin EP Impurity A |
30246-33-4 |
C11H12N4O3S3 |
344.43 |
Yellowish Brown Solid |
-20°C Freezer,dry,dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑林杂质B |
98.83% |
Cefazolin EP Impurity B |
N/A |
C16H20N4O4S3 |
428.55 |
White powder |
-20°C Freezer,dry,dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑林杂质C |
99.92% |
Cefazolin EP Impurity C |
56842-77-4 |
C11H12N6O4S |
324.32 |
Off-White Solid |
-20°C Freezer,dry,dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑林杂质D |
98.67% |
Cefazolin EP Impurity D |
N/A |
C13H14N6O6S |
382.35 |
White powder |
-20°C Freezer,dry,dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑林杂质G(头孢唑林USP杂质I) |
96.43% |
Cefazolin EP Impurity G |
1172998-53-6 |
C11H10N6O4S |
322.3 |
Off-White Solid |
-20°C Freezer,dry,dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑林USP杂质E(带盐) |
99.02% |
Cefazolin USP Impurity E |
N/A |
C11H12N6O5S |
340.32 |
White powder |
-20°C Freezer,dry,dark |
2年 |
28mg 2018-8-20 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑林杂质9(S氧化物) |
98.48% |
Cefazolin Impurity 9(Sulfur Oxide) |
N/A |
C14H14N8O5S3 |
470.51 |
Off-white powder |
-20°C Freezer,dry,dark |
2年 |
103mg 2018-9-21 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑林杂质L(头孢唑林USP杂质M) |
96.59% |
Cefazolin Impurity L |
N/A |
C14H14N8O4S3 |
454.51 |
类白色固体 |
-40°C Freezer,dry,dark |
不稳定,有效期半年 |
50mg 2019-01-24 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑林杂质J |
94.77% |
Cefazolin Impurity J |
N/A |
C11H12N6O5S |
340.32 |
浅黄色粉末 |
-40°C Freezer,dry,dark |
|
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑林杂质K |
95.93% |
Cefazolin EP Impurity K |
1322626-65-2 |
C14H15N9O3S3 |
453.52 |
Pale Yellow Solid |
-20°C Freezer,dry,dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟系列 |
头孢噻肟杂质A |
97.07% |
Cefotaxime Sodium EP Impurity A |
65052-63-3 |
C14H15N5O5S2 |
397.43 |
White to Off-White Solid |
Hygroscopic, -20°C Freezer, Under inert atmosphere |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟杂质B |
99.48% |
Cefotaxime Sodium EP Impurity B |
66340-28-1 |
C14H15N5O6S2 |
413.43 |
Pale Yellow Solid |
20°C Freezer, Under inert atmosphere |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟杂质C |
97.14% |
Cefotaxime Sodium EP Impurity C |
66403-32-5 |
C17H17N5O8S2 |
483.48 |
Pale Yellow Solid |
-20°C Freezer,dry,dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟钠EP杂质E(头孢曲松杂质B) |
96.02% |
Cefotaxime EP Impurity E |
66340-33-8 |
C14H13N5O5S2 |
395.41 |
Off-White Solid |
-20°C Freezer,dry,dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟钠EP杂质D |
95.27% |
Cefotaxime EP Impurity D |
N/A |
C16H17N5O7S2 |
455.47 |
类白色粉末 |
-40°C Freezer,dry,dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟钠开环杂质(头孢噻肟USP杂质D) |
97.61% |
Cefotaxime Ring-Opened Impurity |
N/A |
C14H15N5O6S2 |
413.43 |
Off-white solid |
-20°C Freezer,dry,dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟钠EP杂质G |
99.01% |
Cefotaxime EP Impurity G |
N/A |
C22H22N8O9S3 |
638.65 |
类白色粉末 |
-20°C Freezer,dry,dark |
|
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟钠相关杂质6 |
97.61% |
Cefotaxime related Impurity 6 |
N/A |
C14H15N5O6S2 |
413.43 |
Off-white solid |
-20°C Freezer,dry,dark |
|
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟杂质23 |
95.90% |
Cefotaxime Impurity 23 |
N/A |
C8H8N2O3S |
212.23 |
类白色粉末 |
-40°C Freezer,dry,dark |
室温不稳定 |
382mg
2020-2-28 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟杂质15 |
98.54% |
Cefotaxime Impurity 15 |
N/A |
C6H8N4O2S |
200.22 |
Off-white powder |
-20°C Freezer,dry,dark |
2年 |
166mg 2018-9-21 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟氧化杂质1 |
97.14% |
Cefotaxime Oxide impurity 1 |
N/A |
C16H17N5O8S2 |
471.46 |
White powder |
-20°C Freezer,dry,dark |
常温不稳定 |
48mg 2018-12-13 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟杂质F |
97.64% |
Cefotaxime EP Impurity F |
175032-97-0 |
C30H30N10O12S4 |
850.88 |
White powder |
-20°C Freezer,dry,dark |
常温不稳定 |
25mg 2018-12-28 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
(6R,7S)-头孢噻肟 |
92.35% |
(6R,7S)-Cefotaxime |
N/A |
C16H17N5O7S2 |
455.47 |
Light yellow to off-white powder |
-40°C Freezer,dry,dark |
不稳定 |
30mg 2019-01-04 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟杂质13(二聚体) |
99.13% |
Cefotaxime Impurity 13 |
N/A |
C32H32N10O13S4 |
892.92 |
Light yellow to off-white powder |
-20°C Freezer,dry,dark |
常温不稳定 |
17mg 2019-01-04 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟杂质G△3异构体 |
92.15% |
CefotaximeEP Impurity G△3 Isomer |
N/A |
C22H22N8O9S3 |
638.65 |
Light yellow powder |
-20°C ,dark |
不稳定 |
114mg 2019-08-22 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟双键位移杂质 |
99.70% |
Cefotaxime △3 Impurity |
N/A |
C16H17N5O7S2 |
455.47 |
类白色粉末 |
-20°C ,dark |
|
83mg 2018-11-06 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻肟杂质4 |
99.72% |
Cefotaxime Sodium Impurity 4 |
149-30-4 |
C7H5NS2 |
167.25 |
Pale Yellow Solid |
-20°C Freezer,dry,dark |
2年 |
260mg
2018-5-10 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢拉定系列 |
头孢拉定杂质C |
99.13% |
Cefradine EP Impurity C |
N/A |
C16H19N3O5S |
365.4 |
Off-white powder |
Hygroscopic, -40°C Freezer, Under inert atmosphere |
2年 |
50mg 2019-03-25 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢拉定杂质D |
97.00% |
Cefradine EP Impurity D |
N/A |
C16H19N3O5S |
365.4 |
N/A |
Hygroscopic, -20°C Freezer, Under inert atmosphere |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢拉定杂质D |
97.03% |
Cefradine EP Impurity D |
N/A |
C16H19N3O5S |
365.4 |
Off-white powder |
-20°C Freezer,dark |
不稳定 |
115mg 2019-03-28 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢拉定手性异构体 |
95.72% |
Cefradine chirality isomer |
30959-67-2 |
C16H19N3O4S |
349.4 |
类白色粉末 |
-20°C Freezer,dark |
不稳定 |
196mg 2019-08-07 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢拉定杂质1(二氢头孢拉定) |
98.23% |
Cefradine Impurity 1(4',5'-dihydrocefradine) |
37051-00-6 |
C16H21N3O4S |
351.42 |
Off-white powder |
-20°C Freezer |
2年 |
108mg 2018-9-21 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢拉定双母核 |
99.22% |
|
N/A |
C24H27N5O6S2 |
545.63 |
Light yellow to off-white powder |
-20°C Freezer |
|
25mg 2019-10-14 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
特戊酰胺头孢拉定 |
98.91% |
|
N/A |
C21H27N3O5S |
433.52 |
浅黄至类白粉末 |
-20°C Freezer |
|
53mg 2019-10-09 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢拉定二聚体 |
95.54% |
Cefradine Dimer |
N/A |
C32H36N6O7S2 |
680.79 |
类白色粉末 |
-20°C Freezer |
|
43mg 2019-11-20 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢拉定杂质F
头孢氨苄杂质D |
99.50% |
Cefradine EP Impurity F
(Cefalexin EP Impurity D) |
34876-35-2 |
C5H6O2S |
130.16 |
Light Yellow Solid |
Hygroscopic, Refrigerator, under inert atmosphere |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢拉定杂质G
头孢氨苄杂质E |
99.34% |
Cefradine EP Impurity G
(Cefalexin EP Impurity E) |
146794-70-9 |
C13H18N2O4S |
298.36 |
White Solid |
-20°C Freezer |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢硫脒系列 |
头孢硫脒氧化杂质 |
99.04% |
Ceftazidime Oxide Impurity |
N/A |
C19H28N4O7S2 |
488.58 |
Light yellow to white powder |
-20°C Freezer |
2年 |
114mg |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢硫脒杂质1 |
97.44% |
Cefathiamidine Impurity 1 |
26973-80-8 |
C12H13BrN2O6S |
393.21 |
Off-White Solid |
-20°C Freezer |
2年 |
2.61g
2018-6-11 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢硫脒杂质3 |
97.81% |
Cefathiamidine Impurity 3 |
N/A |
C19H28N4O6S2 |
472.58 |
Light yellow to white powder |
-20°C Freezer |
2年 |
110mg |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢硫脒杂质5 |
98.37% |
Cefathiamidine Impurity 5 |
40818-86-8 |
C10H11ClN2O4S |
290.72 |
White powder |
-20°C Freezer |
2年 |
1.44g |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢硫脒杂质4 |
98.50% |
Cefathiamidine Impurity 4 |
28307-26-8 |
C12H12Cl2N2O6S |
383.2 |
White powder |
-20°C Freezer |
2年 |
4.0g 2018-6-13 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢硫脒杂质10 |
99.93% |
Cefathiamidine Impurity 10 |
N/A |
C17H24N4O4S2 |
412.53 |
Pale yellow powder |
-20°C Freezer |
2年 |
105mg 2018-7-12 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢硫脒杂质11 |
97.08% |
Cefathiamidine Impurity 11 |
N/A |
C10H11ClN2O5S |
306.72 |
White powder |
-20°C Freezer |
2年 |
102mg 2018-7-12 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢硫脒杂质12 |
98.67% |
Cefathiamidine Impurity 12 |
N/A |
C17H26N4O6S2 |
446.54 |
White powder |
-20°C Freezer |
2年 |
101mg 2018-7-12 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢硫脒杂质2 |
98.41% |
Cefathiamidine Impurity 2 |
N/A |
C17H26N4O4S2 |
414.54 |
Pale yellow powder |
-20°C Freezer |
2年 |
108mg 2018-7-12 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢硫脒杂质8 |
97.32% |
Cefathiamidine Impurity 8 |
N/A |
C10H11BrN2O5S |
351.17 |
White powder |
-20°C Freezer |
2年 |
105mg 2018-7-18 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢硫脒杂质14 |
96.06% |
Cefathiamidine Impurity 14 |
744191-99-9 |
C9H18N2O2S |
218.32 |
White powder |
-20°C Freezer |
2年 |
104mg 2018-7-18 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢硫脒杂质6 |
98.29% |
Cefathiamidine Impurity 6 |
28240-16-6 |
C12H13ClN2O6S |
348.76 |
Off-White Solid |
-20°C Freezer |
2年 |
2.69g
2018-6-11 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢硫脒杂质9 |
97.90% |
Cefathiamidine Impurity 9 |
N/A |
C17H26N4O5S2 |
430.54 |
Off-White Solid |
-20°C Freezer |
2年 |
107mg 2018-7-27 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢硫脒中间体内酯(头孢硫脒杂质18) |
93.44% |
Cefathiamidine Impurity 18 |
N/A |
C10H9BrN2O4S |
333.16 |
浅黄至类白色粉末 |
-20°C Freezer |
常温不稳定 |
211mg 2019-06-19 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢硫脒杂质15 |
96.71% |
Cefathiamidine Impurity 15 |
N/A |
C10H11BrN2O4S |
335.17 |
off-white powder |
-20°C Freezer |
2年 |
160mg
2018-7-27 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢丙烯系列 |
头孢丙烯杂质D |
99.09% |
Cefprozil Impurity D |
106447-44-3 |
C10H12N2O3S |
240.28 |
Off-White Solid |
-86°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
甲氧基头孢羟氨苄(头孢丙烯杂质4) |
97.44% |
Cefprozil Impurity 4 |
N/A |
C17H19N3O6S |
393.41 |
浅黄至类白色粉末 |
-20°C, dry, dark |
常温不稳定 |
105mg 2018-12-04 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢丙烯杂质F |
97.64% |
Cefprozil Impurity F |
107937-01-9 |
C10H12N2O3S |
240.28 |
Light Yellow Powder |
-86°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢孟多酯 |
头孢孟多酯杂质A |
98.43% |
Cefamandole Impurity A |
N/A |
C17H16N2O6S |
376.38 |
Off-White Solid |
-10℃-0℃, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢孟多酯杂质C |
99.12% |
Cefamandole Impurity C |
N/A |
C20H20N6O6S2 |
504.54 |
Off-White Solid |
-10℃-0℃, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢孟多酯杂质E |
97.77% |
Cefamandole Impurity E |
87932-78-3 |
C19H18N2O8S |
434.42 |
Off-White Solid |
-10℃-0℃, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
S-头孢孟多酯酸 |
97.65% |
S-Cefamandole |
N/A |
C19H18N6O6S2 |
490.51 |
Light yellow to off-white solid |
-20°C, dry, dark |
常温不稳定 |
147mg 2019-03-11 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢孟多杂质B |
98.79% |
Cefamandole Impurity B |
N/A |
C18H18N6O5S2 |
462.5 |
Light Yellow Powder |
-20°C, dry, dark |
常温不稳定 |
112mg 2019-03-29 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢孟多酯钠杂质5 |
98.94% |
Cefamandole Sodium Impurity 5 |
42540-40-9
(free acid) |
C19H18N6O6S2 |
490.51 |
Off-White Solid |
-20°C, dry, dark |
2年 |
300mg
2018-5-10 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢哌酮系列 |
头孢哌酮杂质A |
96.22% |
Cefoperazone Impurity A |
73240-08-1 |
C23H23N5O8S |
529.52 |
White Solid |
-10℃-0℃, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢哌酮杂质D |
98.22% |
Cefoperazone Impurity D |
37539-03-0 |
C10H11N5O3S2 |
313.36 |
Yellowish crystals |
-10℃-0℃, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢哌酮杂质6 |
98.46% |
Cefoperazone Impurity 6 |
N/A |
C23H25N5O8S |
531.54 |
Off-White Solid |
-20°C, dry, dark |
2年 |
360mg
2018-5-10 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢哌酮杂质10 |
99.15% |
Cefoperazone Impurity 10 |
N/A |
C25H27N9O9S2 |
661.67 |
Off-White Solid |
-20°C, dry, dark |
2年 |
260mg
2018-5-10 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢哌酮杂质11 |
99.39% |
Cefoperazone Impurity 11 |
N/A |
C35H37N15O10S4 |
956.02 |
Off-White Powder |
-20°C, dry, dark |
2年 |
59mg 2018-9-11 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢菌素C衍生(头孢哌酮杂质18) |
97.42% |
Cefoperazone Impurity 18 |
N/A |
C16H21N7O6S2 |
471.51 |
类白色粉末 |
-20°C, dry, dark |
常温不稳定 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢哌酮异构体(头孢哌酮杂质16) |
97.09% |
Cefoperazone Impurity 16 |
68779-10-2 |
C25H27N9O8S2 |
645.67 |
类白色粉末 |
-20°C, dry, dark |
常温不稳定 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢哌酮开环杂质 |
99.47% |
Cefoperazone
Ring-Opened
Impurity |
N/A |
C25H29N9O9S2 |
663.68 |
Off-White Powder |
-20°C, dry, dark |
2年 |
122mg
2018-7-27 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢他啶系列 |
头孢他啶杂质C |
98.96% |
Ceftazidime EP Impurity C |
3432-88-0 |
C13H13N3O3S |
291.33 |
White to yellow solid |
2-8°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢他啶杂质H |
99.44% |
Ceftazidime EP Impurity H |
1354396-23-8 |
C23H24N6O7S2 |
560.6 |
White solid |
Hygroscopic, -20°C Freezer, Under inert atmosphere |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢他啶杂质B |
90.60% |
Ceftazidime Impurity B |
97148-38-4 |
C22H22N6O7S2 |
546.58 |
off-white powder |
Hygroscopic, -20°C Freezer, Under inert atmosphere |
2年 |
24mg 2018-7-12 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢他啶杂质G |
95.16% |
Ceftazidime EP Impurity G |
194241-83-3 |
C11H14N4Na2O8S2 |
440.36 |
Light yellow powder |
Hygroscopic, -40°C Freezer, Under inert atmosphere |
不稳定 |
138mg 2018-11-19 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢他啶(7S)异构体 |
91.55% |
Ceftazidime (7S) Isomer |
N/A |
C22H22N6O7S2 |
546.58 |
浅黄色固体 |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢他啶EP杂质E |
97.28% |
Ceftazidime EP Impurity E |
102772-66-7 |
C26H30N6O7S2 |
602.68 |
Off-white powder |
-20°C, dry, dark |
2年 |
98mg 2018-9-7 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢他啶杂质D |
96.44% |
Ceftazidime Impurity D |
N/A |
C45H44N6O7S2 |
845 |
类白色粉末 |
-20°C, dry, dark |
2年 |
55mg 2018-9-06 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢他啶EP杂质A |
96.65% |
Ceftazidime EP Impurity A |
1000980-60-8 |
C22H22N6O7S2 |
546.58 |
Light yellow solid |
-40°C, dry, dark |
|
83mg 2018-11-01 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢他啶内酯 |
98.89% |
Ceftazidime Lactone |
N/A |
C17H17N5O7S2 |
467.48 |
类白色固体 |
-20°C, dry, dark |
2年 |
10mg 2019-01-09 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢他啶氧化杂质 |
98.98% |
Ceftazidime oxide Impurity |
N/A |
C22H22N6O8S2 |
562.58 |
Off-White to Pale yellow Solid |
Hygroscopic, -20°C Freezer, Under inert atmosphere |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢泊肟酯系列 |
头孢泊肟酯母核 |
96.65% |
7-AMCA |
24701-69-7 |
C9H12N2O4S |
244.27 |
Light yellow powder |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢泊肟酯EP杂质A |
95.19% |
Cefpodoxime Proxetil EP Impurity A |
80210-62-4 |
C15H17N5O6S2 |
427.46 |
Off-White Solid |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢泊肟酯EP杂质B |
98.18% |
Cefpodoxime Proxetil EP Impurity B |
947692-14-0 |
C20H25N5O8S2 |
527.57 |
Off-White Solid |
-20°C, dry, dark |
2年 |
12mg
2018-3-29 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢泊肟酯EP杂质E |
96.91% |
Cefpodoxime Proxetil EP Impurity E |
217803-89-9 |
C22H27N5O10S2 |
585.61 |
Off-White Solid |
-20°C, dry, dark |
2年 |
打核磁用完了 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢泊肟酯EP杂质F |
99.14% |
Cefpodoxime Proxetil EP Impurity F |
96680-30-7 |
C22H27N5O10S2 |
585.61 |
Off-White Solid |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢泊肟酯EP杂质G |
97.15% |
Cefpodoxime Proxetil EP Impurity G |
947692-15-1 |
C23H29N5O10S2 |
599.63 |
Off-White Solid |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢泊肟酯EP杂质J |
98.08% |
Cefpodoxime Proxetil EP Impurity J |
N/A |
C23H29N5O11S2 |
615.63 |
Light yellow powder |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢泊肟酯杂质I |
99.36% |
Cefpodoxime Proxetil Impurity I |
N/A |
C25H33N5O11S2 |
643.69 |
Off-White Solid |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢泊肟酯杂质3 |
98.72% |
Cefpodoxime Proxetil Impurity 3 |
N/A |
C43H52N10O19S4 |
1141.19 |
淡黄色固体 |
-20°C, dry, dark |
2年 |
46mg 2018-10-19 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢泊肟酯杂质5 |
95.10% |
Cefpodoxime Proxetil Impurity 5 |
N/A |
C36H42N10O14S4 |
967.04 |
白色固体 |
-20°C, dry, dark |
2年 |
78mg 2018-11-09 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢泊肟酯S氧化杂质 |
96.38% |
Cefpodoxime Proxetil S Oxide Impurity |
N/A |
C21H27N5O10S2 |
573.6 |
Off-White Solid |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地尼系列 |
头孢地尼杂质2 |
97.95% |
Cefdinir Impurity 2 |
178949-03-6 |
C7H8N4O4S |
244.23 |
Off-White Solid |
-20°C, dry, dark |
2年 |
380mg
2018-3-29 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
乙酰头孢地尼杂质 |
99.03% |
N-Acetyl Cefdinir |
N/A |
C16H15N5O6S2 |
437.45 |
Off-White Solid |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地尼杂质A |
97.09% |
Cefdinir Impurity A |
1450758-21-0 |
C5H6N4O2S |
186.19 |
Off-White Solid |
-20°C, dry, dark |
2年 |
480mg
2018-3-29 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地尼杂质C |
98.88% |
Cefdinir Impurity C |
79349-82-9 |
C9H10N2O3S |
226.25 |
|
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地尼杂质D |
99.61% |
Cefdinir Impurity D |
934986-48-8 |
C14H13N5O6S2 |
411.41 |
Off-White Solid |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地尼杂质F
(△2-头孢地尼)(只能用于定性) |
98.73% |
Cefdinir Impurity F
(△2-Cefdinir) |
934986-49-9 |
C14H13N5O5S2 |
395.41 |
Light yellow powder |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地尼杂质G |
97.13% |
Cefdinir Impurity G |
71091-93-5 |
C13H13N5O5S2 |
383.4 |
Off-White Solid |
-20°C, dry, dark |
2年 |
135mg
2018-3-29 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地尼杂质E |
97.77% |
Cefdinir Impurity E |
178422-39-4 |
C14H15N5O6S2 |
413.43 |
类白色粉末 |
-20°C, dry, dark |
不稳定 |
39mg 2019-06-05 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地尼聚合物2 |
96.73% |
N/A |
N/A |
C28H24N10O9S4 |
772.81 |
浅黄色粉末 |
-20°C, dry, dark |
|
22 mg 2019-06-24 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地尼聚合物1 |
95.17% |
N/A |
N/A |
C28H26N10O10S4 |
790.83 |
类白色粉末 |
-20°C, dry, dark |
|
14mg 2019-07-03 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地尼杂质IJKL混合物 |
98.92% |
Cefdinir impurity IKLmixture |
N/A |
C14H15N5O6S2 |
413.43 |
类白色粉末 |
-20°C, dry, dark |
|
135mg 2019-07-05 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地尼杂质R |
92.44% |
Cefdinir Impurity R |
N/A |
C14H13N5O5S2 |
395.41 |
类白色粉末 |
-40°C, dry, dark |
|
105mg 2019-07-12 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地尼异噁唑 |
99.07% |
Cefdinir isoxazole |
1356842-10-8 |
C13H11N3O6S |
337.31 |
黄色粉末 |
-20°C, dry, dark |
不稳定,强引湿性 |
15mg 2019-07-12 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地尼杂质TU混合物 |
95.68% |
Cefdinir Impurity TU mixture |
N/A |
C13H15N5O4S2 |
369.42 |
浅黄色粉末 |
-20°C, dry, dark |
|
81mg 2019-07-18 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地尼杂质N |
94.15% |
Cefdinir Impurity N |
N/A |
C14H13N5O5S2 |
395.41 |
类白色粉末 |
-40°C, dry, dark |
|
46mg 2019-07-26 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地尼杂质S |
96.49% |
Cefdinir Impurity S |
127770-93-8 |
C16H15N5O6S2 |
437.45 |
Light yellow powder |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢曲松系列 |
△3-头孢曲松异构体 |
99.74% |
Ceftriaxone △3 isomer |
N/A |
C18H18N8O7S3 |
554.58 |
Off-White Solid |
-40°C, dry, dark |
2年 不稳定 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢曲松二聚体 |
95.10% |
Ceftriaxone Dimer |
N/A |
C36H34N16O13S6 |
1091.14 |
浅黄色粉末 |
-20°C, dry, dark |
2年 |
25.8mg 2018-12-13 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢曲松杂质I |
95.22% |
Ceftriaxone EP Impurity I |
N/A |
C18H18N8O8S3 |
570.58 |
Light yellow to off-white powder |
-20°C, dry, dark |
2年 |
69mg 2019-01-01 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢曲松EP杂质E |
96.88% |
Ceftriaxone EP Impurity E |
58909-56-1 |
C12H13N5O5S2 |
371.39 |
Light yellow powder |
-20°C, dry, dark |
2年 |
240mg
2018-3-29 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛系列 |
头孢呋辛钠EP杂质B |
97.17% |
Cefuroxime sodium EP impurity B |
39685-31-9 |
C17H17N3O8S |
423.4 |
Off-White Solid |
-20°C, dry, dark |
2年 |
22mg
2018-5-10 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛钠EP杂质C |
96.12% |
Cefuroxime sodium EP impurity C |
69822-88-4 |
C15H15N3O6S |
365.36 |
Off-White Solid |
-20°C, dry, dark |
2年 |
140mg
2018-3-29 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛钠EP杂质I |
97.17% |
Cefuroxime sodium EP impurity I |
39684-61-2 |
C7H7NO4 |
169.13 |
White Solid |
-20°C, dry, dark |
2年 |
100mg
2018-3-29 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛酯二聚体1 |
94.19% |
Cefuroxime Axetil Dimer 1 |
N/A |
C34H34N8O16S2 |
874.81 |
浅黄至类白色粉末 |
-40°C, dry, dark |
2年 |
53mg 2018-11-05 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛钠EP-H (头孢呋辛酯杂质E USP) |
98.37% |
Cefuroxime sodium EP impurity H |
N/A |
C15H13N3O6S |
363.35 |
Off-White powder |
-20°C, dry, dark |
2年 |
119mg 2018-10-10 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛钠EP-A |
96.93% |
Cefuroxime sodium EP impurity A |
56271-94-4 |
C15H15N3O7S |
381.36 |
Off-White powder |
-20°C, dry, dark |
2年 |
107mg 2018-10-10 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛酯杂质B(USP) |
99.05% |
Cefuroxime Axetil impueity B |
N/A |
C20H22N4O10S |
510.47 |
Off-White powder |
-40°C, dry, dark |
不稳定 |
54mg 2018-10-12 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛酯杂质C |
90.55% |
Cefuroxime Axetil impueity C |
N/A |
C18H15Cl3N4O10S |
585.76 |
Off-White powder |
-86°C, dry, dark |
极不稳定- 现做出货 干冰出货保质期两周
|
71mg 2018-10-11 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛钠EP杂质E |
97.02% |
Cefuroxime EP Impurity E |
97232-97-8 |
C16H16N4O8S |
424.39 |
Off-White powder |
-40°C, dry, dark |
不稳定 |
40mg 2018-10-17 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛钠EP杂质G |
98.76% |
Cefuroxime EP Impurity G |
97232-98-9 |
C17H17N3O8S |
423.4 |
浅黄至类白色 |
-40°C, dry, dark |
不稳定 |
40mg 2018-10-19 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛EP杂质F |
96.64% |
Cefuroxime EP Impurity F |
97170-19-9 |
C15H15N3O7S |
381.36 |
Off-White powder |
-20°C, dry, dark |
2年 |
50mg
2018-6-07 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛酯氧化杂质 |
97.40% |
Cefuroxime Axetil Oxide Impueity |
N/A |
C20H22N4O11S |
526.47 |
Light yellow powder |
-40°C, dry, dark |
不稳定 |
123mg
2018-10-26 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛钠杂质M |
95.32% |
Cefuroxime EP Impurity M |
N/A |
C16H16N4O8S |
424.39 |
Off-White powder |
-40°C, dry, dark |
不稳定 |
39mg 2018-11-19 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛钠二聚体 |
99.04% |
Cefuroxime sodium Dimer |
N/A |
C23H23N5O8S2 |
561.59 |
类白色粉末 |
-20°C, dry, dark |
常温不稳定 |
100mg 2020-03-03 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛钠二聚体△3异构体 |
99.79% |
Cefuroxime sodium Dimer △3 isomer |
N/A |
C23H23N5O8S2 |
561.59 |
类白色粉末 |
-20°C, dry, dark |
常温不稳定 |
119mg 2019-12-12 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛钠杂质L |
95.01% |
Cefuroxime Impurity L |
N/A |
C16H16N4O8S |
424.39 |
White Solid |
-40°C, dry, dark |
不稳定 |
32mg 2019-01-30 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛钠氧化杂质 |
99.81% |
Cefuroxime Sodium Oxide Impurity |
N/A |
C16H16N4O9S |
440.38 |
Off-White powder |
-40°C, dry, dark |
不稳定 |
133mg
2018-10-26 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢替唑系列 |
头孢替唑杂质3 |
98.19% |
Ceftezole Impurity 3 |
24209-43-6 |
C10H10N4O3S3 |
330.41 |
Off-White Solid |
-20°C, dry, dark |
2年 |
110mg
2018-5-10 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢替唑杂质20 |
99.22% |
Ceftezole Impurity 20 |
N/A |
C15H18N4O4S3 |
414.52 |
Off-White Solid |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢替唑内酯 |
99.76% |
Ceftezole Lactone |
N/A |
C11H10N6O4S |
322.3 |
类白色粉末 |
-20°C, dry, dark |
2年 |
213mg 2018-6-21 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
(6R,7S)-头孢替唑 |
96.08% |
Ceftezole (6R,7S) Impurity |
N/A |
C13H12N8O4S3 |
440.48 |
类白色固体 |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢替唑开环杂质 |
93.42% |
Ceftezole ring-opened Impurity |
N/A |
C13H14N8O5S3 |
458.5 |
浅黄至类白色固体 |
-20°C, dry, dark |
不稳定 |
107mg 2018-11-15 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢替唑双键异构体杂质 |
91.14% |
Ceftezole Impurity 21 |
N/A |
C13H12N8O4S3 |
440.48 |
Off-White Solid |
-40°C, dry, dark |
|
106mg 2019-01-30 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢替唑氧化杂质 |
97.17% |
Ceftezole Impurity Oxide |
N/A |
C13H12N8O5S3 |
456.48 |
White Solid |
-20°C, dry, dark |
2年 |
135mg
2018-6-12 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢米诺系列 |
头孢米诺氧化杂质1(M535-1) |
95.03% |
Cefminox Oxide Impurity 1 |
N/A |
C16H21N7O8S3 |
535.58 |
类白色粉末 |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢米诺杂质19 (头孢米诺杂质17) |
92.59% |
Cefminox Impurity 19 |
N/A |
C13H15ClN6O5S2 |
434.88 |
Off-White Solid |
-20°C, dry, dark |
2年 |
102mg 2018-8-3 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢米诺杂质18 |
95.44% |
Cefminox Impurity 18 |
N/A |
C15H18N10O5S3 |
514.56 |
Off-White Solid |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢米诺杂质4 |
97.83% |
Cefminox Impurity 4 |
N/A |
C16H21N3O9S2 |
463.48 |
类白色粉末状固体 |
-20°C, dry, dark |
2年 |
183mg 2019-12-13 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢米诺杂质12 |
97.83% |
Cefminox Impurity 12 |
N/A |
C14H19N3O7S2 |
405.45 |
Off-White Solid |
-20°C, dry, dark |
|
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢米诺钠杂质2 |
98.99% |
Cefminox Sodium Impurity 2 |
51138-06-8 |
C2H3N4NaS |
138.13 |
黄色粉末 |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻吩系列 |
头孢噻吩-3-异构体 |
98.82% |
Cephalothin 3-isomer |
N/A |
C16H16N2O6S2 |
396.44 |
类白色粉末 |
-20°C, dry, dark |
室温不稳定 |
122mg 2019-08-28 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
去乙酰头孢噻吩酸 |
98.38% |
N/A |
N/A |
C14H14N2O5S2 |
354.4 |
浅黄色粉末 |
-20°C, dry, dark |
不稳定极易吸潮 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢噻吩钠EP杂质A |
95.49% |
Cephalothin Sodium EP Impurity A |
34691-02-6 |
C14H14N2O4S2 |
338.4 |
Off-White Solid |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克肟系列 |
头孢克肟甲酯 |
98.90% |
Cefixime Methyl Ester |
88621-01-6 |
C17H17N5O7S2 |
467.49 |
白色粉末 |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克肟△3异构体 |
99.84% |
Cefixime △3 isomer |
N/A |
C16H15N5O7S2 |
453.45 |
White powder |
-20°C, dry, dark |
2年 |
60mg 2018-7-12 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克肟叔丁酯 |
98.10% |
Cefixime tert-Butyl Ester |
N/A |
C20H23N5O7S2 |
509.56 |
Off-White Solid |
-20°C, dry, dark |
2年 |
103mg 2018-7-18 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克肟EP杂质E |
99.84% |
Cefixime EP Impurity E |
N/A |
C15H15N5O7S2 |
441.44 |
Off-White Solid |
-20°C, dry, dark |
2年 |
105mg 2018-7-27 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克肟EP杂质C |
99.43% |
Cefixime EP Impurity C |
N/A |
C16H15N5O7S2 |
453.45 |
Off-White Solid |
-20°C, dry, dark |
2年 |
26mg 2018-7-27 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克肟氧化杂质(头孢克肟亚砜) |
98.86% |
Cefixime Oxide Impurity(Cefixime Sulfoxide) |
1335555-87-7 |
C16H15N5O8S2 |
469.45 |
Off-white powder |
-20°C, dry, dark |
2年 |
148mg 2018-9-26 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克肟杂质F |
97.13% |
Cefixime EP Impurity F |
N/A |
C18H19N5O7S2 |
481.5 |
Off-White Solid |
-20°C, dry, dark |
2年 |
125mg
2018-6-12 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克肟乙酯-内酰胺开环物 |
97.06% |
Cefixime ethyl ester ring opening adduct |
N/A |
C18H21N5O8S2 |
499.52 |
Light yellow to white-like powder |
-20°C, dry, dark |
常温不稳定 |
50mg 2019-10-09 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克肟甲酯-内酰胺开环物 |
92.84% |
Cefixime Methyl Ester ring opening adduct |
N/A |
C17H19N5O8S2 |
485.49 |
Light yellow to white powder |
-20°C, dry, dark |
|
58mg 2019-11-01 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克肟内酯 |
95.13% |
Cefixime Lactone |
N/A |
C16H15N5O7S2 |
453.45 |
Pale yellow powder |
-20°C, dry, dark,惰性气体保护 |
强引湿性,常温不稳定 |
60mg 2019-10-14 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克肟EP杂质B |
98.66% |
Cefixime EP Impurity B |
1335475-19-8 |
C15H17N5O6S2 |
427.46 |
类白色粉末 |
-20°C, dry, dark |
2年 |
59mg 2019-06-03 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克肟EP杂质A |
99.31% |
Cefixime EP Impurity A |
1335475-08-5(错误)1614255-90-1(正确) |
C16H17N5O8S2 |
471.46 |
Off-white powder |
-20°C, dry, dark |
不稳定 |
85mg 2019-05-06 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克肟杂质3 |
99.66% |
Cefixime Impurity 3 |
N/A |
C18H19N5O7S2 |
481.5 |
Off-White Solid |
-20°C, dry, dark |
2年 |
114mg 2018-12-28 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克肟杂质4 |
99.09% |
Cefixime Impurity 4 |
N/A |
C17H17N5O7S2 |
467.48 |
Light yellow to white powder |
-20°C, dry, dark |
2年 |
57mg 2018-12-28 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克肟杂质2(头孢克肟亚砜异构体) |
99.12% |
Cefixime Impurity 2(Cefixime Sulfoxide isomer) |
N/A |
C16H15N5O8S2 |
469.45 |
Off-White Solid |
-40°C, dry, dark |
2年 |
68mg
2018-10-26 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟系列 |
头孢唑肟钠异构体 |
97.85% |
(E)-Ceftizoxime Impurity |
N/A |
C13H13N5O5S2 |
383.4 |
Off-White Solid |
-20°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟△异构体杂质 |
98.35% |
Ceftizoxime Δ3 isomer |
N/A |
C13H13N5O5S2 |
383.4 |
浅黄至类白色固体 |
-20°C, dry, dark |
2年 |
225mg 2018-8-20 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟异构体杂质 |
95.10% |
Ceftizoxime 7S isomer |
N/A |
C13H13N5O5S2 |
383.4 |
浅黄至类白色固体 |
-20°C, dry, dark |
2年 |
100mg 2018-8-20 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟杂质17 |
98.61% |
Ceftizoxime Impurity 17 |
N/A |
C13H13N5O6S2 |
399.4 |
Off-White Solid |
-20°C, dry, dark |
2年 |
105mg 2018-9-11 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟杂质1 |
98.98% |
Ceftizoxime Impurity 1 |
929101-91-7 |
C20H19N7O7S3 |
565.6 |
Light yellow powder |
-20°C, dry, dark |
2年 |
40mg 2018-10-17 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟杂质2 |
96.30% |
Ceftizoxime Impurity 2 |
929101-93-9 |
C19H18N8O7S3 |
566.59 |
yellow powder |
-20°C, dry, dark |
2年 |
35mg 2018-10-17 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟杂质20 |
99.82% |
Ceftizoxime Impurity 20 |
N/A |
C15H14N2O4S |
318.35 |
类白色粉末 |
-20°C, dry, dark |
2年 |
62mg 2018-12-06 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟杂质13 |
90.83% |
Ceftizoxime Impurity 13 |
N/A |
C7H8N2O4S |
216.21 |
黄色粉末 |
-20°C, dry, dark |
极易吸潮 |
27mg 2019-01-09 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟杂质19 |
97.72% |
Ceftizoxime Impurity 19 |
N/A |
C12H13N5O3S2 |
339.39 |
黄色粉末 |
-20°C, dry, dark |
常温不稳定 |
58mg 2019-01-18 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟杂质07 |
90.20% |
Ceftizoxime Impurity 07 |
N/A |
C14H14N4O5S2 |
382.41 |
黄色粉末 |
-20°C, dry, dark |
常温不稳定 |
60mg 2019-01-24 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟杂质21 |
97.09% |
Ceftizoxime Impurity 21 |
N/A |
C9H13N3O3S |
243.28 |
浅黄色粉末 |
-20°C, dry, dark |
不稳定 |
87mg 2019-05-15 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟杂质22(头孢唑肟开环乙酰甲胺) |
91.95% |
Ceftizoxime Impurity 22 |
N/A |
C14H18N6O5S2 |
414.46 |
类白色粉末 |
-20°C, dry, dark |
室温不稳定 |
274mg 2019-12-13 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟二聚体 |
95.43% |
Ceftizoxime dimer |
N/A |
C26H24N10O9S4 |
748.79 |
黄色粉末 |
-20°C, dry, dark |
|
25mg 2019-06-03 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟开环二聚体 |
97.66% |
Ceftizoxime ring-opened dimer |
N/A |
C26H26N10O10S4 |
766.81 |
浅黄至类白粉末 |
-20°C, dry, dark |
|
117mg 2019-10-15 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟钠开环杂质2 |
90.19% |
Ceftizoxime ring-opened Impurity 2 |
N/A |
C13H15N5O6S2 |
401.42 |
白色或类白色固体 |
-20°C, dry, dark |
不稳定 |
143mg 2019-9-18 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢唑肟钠开环杂质 |
95.42% |
Ceftizoxime ring-opened Impurity |
N/A |
C13H15N5O6S2 |
401.42 |
White powder |
-20°C, dry, dark |
2年 |
102mg 2018-6-21 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢吡肟系列 |
头孢吡肟杂质3 |
99.53% |
Cefepime Impurity 3 |
N/A |
C12H12N6O5S2 |
384.39 |
浅黄色粉末 |
-20°C, dry, dark |
稳定 |
165mg 2019-03-20 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢吡肟杂质12 |
98.30% |
Cefepime Impurity 12 |
N/A |
C19H28N4O6S |
440.51 |
浅黄色粉末 |
-20°C, dry, dark |
常温不稳定 |
125mg
2020-01-14 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢吡肟杂质5 |
97.01% |
Cefepime Impurity 5 |
N/A |
C12H16N4O6S |
344.34 |
类白色固体 |
-20°C, dry, dark |
稳定 |
136mg 2019-03-28 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢吡肟杂质4(含盐) |
91.61% |
Cefepime Impurity 4 |
N/A |
C10H12N2O5S |
272.28 |
类白色粉末 |
-40°C, dry, dark |
不稳定 |
740mg 2019-05-05 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢吡肟二聚体 |
93.22% |
Cefepime dimer |
N/A |
C33H36N11O10S4- |
874.97 |
类白色粉末 |
-40°C, dry, dark |
不稳定 |
30mg 2019-05-20 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢吡肟氧化杂质 |
98.19% |
Cefepime Oxide Impurity |
1338489-58-9 |
C19H24N6O6S2 |
496.56 |
浅黄粉末 |
-20°C, dry, dark |
|
74mg 2019-07-03 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢吡肟EP杂质A |
91.57% |
Cefepime EP Impurity A |
N/A |
C19H24N6O5S2 |
480.56 |
类白色粉末 |
-40°C, dry, dark |
不稳定 |
73mg 2019-11-19 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢吡肟杂质10(杂质C亚硫酸氢钠盐) |
98.78% |
Cefepime Impurity 10 |
N/A |
C8H11N4NaO6S2 |
346.32 |
类白色粉末 |
-20°C, dry, dark |
|
170mg 2019-11-29 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢吡肟杂质9 |
99.10% |
Cefepime Impurity 9 |
N/A |
C12H20N4O4S |
316.38 |
类白色粉末 |
-20°C, dry, dark |
|
289mg 2019-12-03 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢吡肟杂质1 |
99.53% |
Cefepime Impurity 1 |
N/A |
C10H16N4O4S |
288.32 |
类白色粉末 |
-20°C, dry, dark |
|
587mg 2019-12-03 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢吡肟杂质B |
90.95% |
Cefepime Impurity B |
N/A |
C25H29N9O7S3 |
663.75 |
黄色粉末 |
-20°C, dry, dark |
|
415mg 201912-13 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢吡肟EP杂质C |
90.69% |
Cefepime EP Impurity C |
N/A |
C8H10N4O3S |
242.26 |
浅黄粉末 |
-40°C, dry, dark |
|
140mg 2019-12-02 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢吡肟EP杂质E |
99.17% |
Cefepime EP Impurity E |
N/A |
C13H19N3O3S |
297.37 |
浅黄粉末 |
-20°C, dry, dark |
|
119mg 2019-12-03 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢吡肟7S异构体 |
95.05% |
Cefepime 7S isomer |
N/A |
C19H24N6O5S2 |
480.56 |
Off-White Solid |
-20°C, dry, dark |
2年 |
26mg 2018-7-12 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克洛系列 |
头孢克洛EP杂质F |
99.87% |
Cefaclor EP Impurity F |
N/A |
C10H8N2O |
172.18 |
Pale yellow powder |
-20°C, dry, dark |
2年 |
122mg 2018-7-18 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克洛二聚体 |
91.18% |
Cefaclor dimer |
|
C30H26Cl2N6O7S2 |
717.6 |
浅黄色粉末 |
-20°C, dry, dark |
|
33mg 2019-12-31 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克洛杂质5 |
96.07% |
Cefaclor Impurity 5 |
N/A |
C21H22N4O |
346.43 |
类白色粉末 |
-20°C |
室温不稳定 |
107mg 2020-3-3 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢克洛EP杂质C |
95.02% |
Cefaclor EP Impurity C |
143059-69-2 |
C15H14ClN3O4S |
367.81 |
White Solid |
-20°C, dry, dark |
2年 |
108mg 2019-02-11 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢西酮系列 |
头孢西酮杂质3 |
97.58% |
Cefazedone Impurity 3 |
70149-63-2 |
C15H13Cl2N3O5S |
418.25 |
Off-white powder |
-20°C, dry, dark |
2年 |
204mg 2018-9-18 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢西酮杂质7(△3异构体) |
98.65% |
Cefazedone Impurity 7(△3 isomer) |
N/A |
C18H15Cl2N5O5S3 |
548.44 |
Off-white powder |
-20°C, dry, dark |
2年 |
120mg
2018-10-26 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢西酮杂质17 |
97.86% |
Cefazedone Impurity 17 |
N/A |
C16H13Cl2N3O5S |
430.26 |
Off-white powder |
-20°C, dry, dark |
2年 |
129mg 2018-9-18 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢西酮内酯杂质 |
97.35% |
Cefazedone Lactone |
N/A |
C15H11Cl2N3O5S |
416.24 |
Off-white powder |
-20°C, dry, dark |
2年 |
102mg 2018-9-26 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢西酮杂质2 |
99.53% |
Cefazedone Impurity 2 |
56187-36-1 |
C17H15Cl2N3O7S |
476.29 |
浅黄至类白色粉末 |
-20°C, dry, dark |
2年 |
214mg 2018-9-11 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢替安系列 |
3-乙酰氧头孢替安 |
97.97% |
3-Deacetylation cefotiam |
58233-18-4 |
C15H16N4O6S2 |
412.44 |
Off-white Solid |
-20°C, dry, dark |
常温不稳定 |
107mg 2019-03-11 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢替安氧化杂质1 |
95.17% |
Cefotiam Oxide Impurity 1 |
N/A |
C18H23N9O5S3 |
541.63 |
White Solid |
-20°C, dry, Under Inert Atmosphere |
2年 |
212mg 2019-01-30 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢西丁系列 |
头孢西丁氧化杂质 |
99.21% |
cefoxitin Oxide impurity |
N/A |
C16H17N3O8S2 |
443.45 |
类白色粉末 |
-20°C, dry, dark |
不稳定 |
215mg 2018-11-19 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
去乙酰氧MOCT |
94.27% |
N/A |
N/A |
C15H16N2O5S2 |
368.43 |
类白色粉末 |
-20°C, dry, dark |
常温不稳定 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢西丁杂质C |
95.09% |
cefoxitin Impurity C |
N/A |
C14H12N2O4S2 |
336.39 |
白色粉末 |
-20°C, dry, dark |
常温不稳定 |
275mg 2019-03-14 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢西丁杂质B |
99.01% |
cefoxitin Impurity B |
N/A |
C16H17N3O7S2 |
427.45 |
类白色粉固体 |
-40°C, dry, dark |
不稳定 |
124mg 2019-03-14 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢卡品酯系列 |
头孢卡品酯杂质4 |
95.46% |
Cefcapene pivoxil impurity 4 |
N/A |
C16H16N4O4S2 |
392.45 |
浅粉色固体 |
-20°C, dry, dark |
2年 |
197mg 2018-12-25 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢卡品酯杂质5 |
99.23% |
Cefcapene pivoxil impurity 5 |
N/A |
C23H29N5O8S2 |
567.64 |
浅黄至类白色粉末 |
-40°C, dry, dark |
不稳定 |
212mg 2018-12-13 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢甲肟系列 |
头孢甲肟杂质4 |
98.34% |
Cefmenoxime Impurity 4 |
126747-52-2 |
C16H17N9O5S3 |
511.56 |
类白色粉末 |
-40°C, dry, dark |
不稳定 |
34mg 2018-12-28 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢甲肟杂质3 |
92.93% |
Cefmenoxime Impurity 3 |
N/A |
C16H17N9O5S3 |
511.56 |
浅黄粉末 |
-40°C, dry, dark |
不稳定 |
32mg 2018-12-28 |
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢地嗪系列 |
头孢地嗪钠E-异构体 |
96.67% |
Cefodizime E-isomer |
N/A |
C20H20N6O7S4 |
584.67 |
浅黄粉末 |
-40°C |
常温不稳定 |
139mg
2020-1-3 |
COA报告、HPLC气相、HNMR核磁、MS质谱 |
|
头孢地嗪钠△3-异构体 |
98.78% |
Cefodizime △3-isomer |
N/A |
C20H20N6O7S4 |
584.67 |
浅黄至类白粉末 |
-40°C |
常温不稳定 |
531mg
2020-1-3 |
COA报告、HPLC气相、HNMR核磁、MS质谱 |
|
(6R,7S)-头孢地嗪 |
96.19% |
(6R,7S)-Cefodizime |
N/A |
C20H20N6O7S4 |
584.67 |
类白色粉末 |
-40°C, dry, dark |
2年 |
100mg 2018-11-16 |
COA报告、HPLC气相、HNMR核磁、MS质谱 |
|
头孢地嗪硫氧化物(亚砜) |
96.90% |
Cefodizime sulfoxide |
N/A |
C20H20N6O8S4 |
600.67 |
Yellow solid |
-20°C Freezer |
2年 |
100mg 2018-7-4 |
COA报告、HPLC气相、HNMR核磁、MS质谱 |
|
头孢呋辛酯系列 |
头孢呋辛酯EP杂质B |
96.08% |
Cefuroxime Axetil |
64544-07-6 |
C20H22N4O10S |
510.47 |
White to pale yellow solid |
2-8°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛 |
99.44% |
Desacetyloxyethyl (E)-Cefuroxime Axetil |
55268-75-2 |
C16H16N4O8S |
424.39 |
White Solid |
2-8°C, dry, dark |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
头孢呋辛杂质5 (头孢呋辛酯二聚体) |
96.00% |
Cefuroxime Impurity 5 |
1202925-10-7 |
C36H38N8O17S2 |
918.86 |
类白色粉末 |
-40, dry, |
2年 |
|
COA报告、HPLC液相、HNMR核磁、MS质谱 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|